Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitalization | 69 | 2022 | 847 | 6.610 |
Why?
|
United States | 102 | 2022 | 4164 | 2.310 |
Why?
|
Postoperative Complications | 7 | 2016 | 103 | 2.110 |
Why?
|
Accidents, Traffic | 6 | 2018 | 15 | 2.110 |
Why?
|
Humans | 137 | 2023 | 18430 | 1.780 |
Why?
|
Emergency Service, Hospital | 10 | 2017 | 382 | 1.760 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2021 | 17 | 1.750 |
Why?
|
Hospital Costs | 10 | 2018 | 41 | 1.720 |
Why?
|
Ambulatory Surgical Procedures | 5 | 2015 | 7 | 1.710 |
Why?
|
Rotavirus Infections | 15 | 2019 | 31 | 1.540 |
Why?
|
Male | 85 | 2023 | 10440 | 1.510 |
Why?
|
Female | 92 | 2023 | 13136 | 1.450 |
Why?
|
Rotavirus Vaccines | 13 | 2019 | 50 | 1.410 |
Why?
|
Middle Aged | 56 | 2022 | 8284 | 1.270 |
Why?
|
Child, Preschool | 55 | 2019 | 1478 | 1.260 |
Why?
|
Infant | 54 | 2019 | 1245 | 1.250 |
Why?
|
Aged | 49 | 2023 | 6417 | 1.250 |
Why?
|
Mandatory Reporting | 2 | 2018 | 3 | 1.240 |
Why?
|
Patient Readmission | 7 | 2017 | 162 | 1.190 |
Why?
|
Length of Stay | 18 | 2016 | 183 | 1.160 |
Why?
|
Adult | 58 | 2021 | 7910 | 1.160 |
Why?
|
Brain Injuries | 4 | 2010 | 14 | 1.120 |
Why?
|
Patient Discharge | 9 | 2021 | 153 | 1.100 |
Why?
|
Arthroplasty, Replacement, Hip | 3 | 2021 | 9 | 1.060 |
Why?
|
Adolescent | 46 | 2019 | 3798 | 1.060 |
Why?
|
Health Services Research | 8 | 2016 | 264 | 1.050 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2023 | 567 | 1.050 |
Why?
|
Retrospective Studies | 23 | 2023 | 2550 | 1.020 |
Why?
|
Wounds and Injuries | 3 | 2016 | 51 | 1.010 |
Why?
|
Aged, 80 and over | 30 | 2022 | 2003 | 0.980 |
Why?
|
Respiratory Syncytial Virus Infections | 8 | 2019 | 24 | 0.980 |
Why?
|
Hysterectomy | 4 | 2016 | 30 | 0.980 |
Why?
|
Databases, Factual | 18 | 2018 | 327 | 0.950 |
Why?
|
Young Adult | 35 | 2019 | 2518 | 0.940 |
Why?
|
Indians, North American | 10 | 2015 | 50 | 0.940 |
Why?
|
Child | 40 | 2019 | 2571 | 0.860 |
Why?
|
Motorcycles | 4 | 2010 | 5 | 0.840 |
Why?
|
Influenza, Human | 8 | 2022 | 282 | 0.820 |
Why?
|
Incidence | 30 | 2022 | 1314 | 0.820 |
Why?
|
Bariatric Surgery | 4 | 2009 | 130 | 0.810 |
Why?
|
Automobile Driving | 2 | 2018 | 10 | 0.780 |
Why?
|
Appointments and Schedules | 2 | 2021 | 34 | 0.770 |
Why?
|
Ambulatory Care Facilities | 3 | 2016 | 77 | 0.770 |
Why?
|
Age Factors | 19 | 2019 | 965 | 0.740 |
Why?
|
Text Messaging | 1 | 2021 | 31 | 0.730 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 7 | 2012 | 19 | 0.710 |
Why?
|
Reminder Systems | 1 | 2021 | 94 | 0.710 |
Why?
|
Telephone | 1 | 2021 | 179 | 0.700 |
Why?
|
Infant, Newborn | 32 | 2019 | 872 | 0.690 |
Why?
|
Gastroenteritis | 8 | 2018 | 25 | 0.680 |
Why?
|
Insurance Coverage | 6 | 2012 | 136 | 0.650 |
Why?
|
Ambulatory Care | 4 | 2019 | 266 | 0.620 |
Why?
|
Hypertension | 1 | 2023 | 524 | 0.620 |
Why?
|
Surgical Procedures, Operative | 2 | 2016 | 17 | 0.610 |
Why?
|
Delivery of Health Care | 2 | 2021 | 444 | 0.610 |
Why?
|
International Classification of Diseases | 2 | 2016 | 87 | 0.600 |
Why?
|
Physician's Role | 1 | 2018 | 32 | 0.600 |
Why?
|
Inpatients | 6 | 2017 | 80 | 0.600 |
Why?
|
Ascites | 1 | 2017 | 1 | 0.580 |
Why?
|
Protein-Energy Malnutrition | 1 | 2017 | 2 | 0.580 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2017 | 5 | 0.570 |
Why?
|
Pressure Ulcer | 1 | 2016 | 5 | 0.560 |
Why?
|
Internationality | 1 | 2016 | 14 | 0.560 |
Why?
|
Robotic Surgical Procedures | 1 | 2016 | 6 | 0.540 |
Why?
|
Head Protective Devices | 3 | 2010 | 4 | 0.540 |
Why?
|
Dementia | 1 | 2018 | 105 | 0.530 |
Why?
|
Quality of Life | 3 | 2021 | 529 | 0.520 |
Why?
|
Medicare | 7 | 2021 | 214 | 0.520 |
Why?
|
Hospital Mortality | 8 | 2017 | 150 | 0.510 |
Why?
|
Laparoscopy | 4 | 2016 | 48 | 0.500 |
Why?
|
Mind-Body Therapies | 2 | 2014 | 10 | 0.490 |
Why?
|
Medicaid | 6 | 2017 | 211 | 0.480 |
Why?
|
Cross-Sectional Studies | 13 | 2017 | 1360 | 0.480 |
Why?
|
Communicable Diseases | 5 | 2016 | 15 | 0.480 |
Why?
|
Seasons | 13 | 2018 | 105 | 0.470 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 7 | 0.470 |
Why?
|
Robotics | 1 | 2014 | 3 | 0.470 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 392 | 0.470 |
Why?
|
Anemia, Sickle Cell | 2 | 2011 | 9 | 0.460 |
Why?
|
Prostatectomy | 1 | 2014 | 79 | 0.450 |
Why?
|
Insurance, Health | 6 | 2017 | 217 | 0.450 |
Why?
|
Diarrhea | 7 | 2018 | 13 | 0.440 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2013 | 6 | 0.440 |
Why?
|
Intention | 1 | 2013 | 28 | 0.440 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 77 | 0.410 |
Why?
|
Quality of Health Care | 3 | 2012 | 347 | 0.400 |
Why?
|
Inuits | 4 | 2014 | 9 | 0.400 |
Why?
|
Rotavirus | 5 | 2019 | 18 | 0.400 |
Why?
|
Fatigue | 2 | 2014 | 35 | 0.400 |
Why?
|
Social Support | 1 | 2013 | 214 | 0.390 |
Why?
|
Health Expenditures | 3 | 2009 | 82 | 0.380 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 298 | 0.380 |
Why?
|
Patient Admission | 5 | 2016 | 76 | 0.380 |
Why?
|
Hospitals, Community | 5 | 2017 | 23 | 0.370 |
Why?
|
Risk Assessment | 8 | 2022 | 1143 | 0.370 |
Why?
|
Practice Patterns, Physicians' | 3 | 2002 | 350 | 0.350 |
Why?
|
Pneumonia, Pneumococcal | 3 | 2015 | 14 | 0.330 |
Why?
|
Time Factors | 8 | 2017 | 1136 | 0.330 |
Why?
|
Managed Care Programs | 4 | 2012 | 347 | 0.320 |
Why?
|
Intussusception | 3 | 2016 | 16 | 0.320 |
Why?
|
Multiple Sclerosis | 1 | 2010 | 97 | 0.320 |
Why?
|
Technology Assessment, Biomedical | 3 | 1997 | 10 | 0.320 |
Why?
|
Age Distribution | 12 | 2018 | 261 | 0.310 |
Why?
|
Sepsis | 2 | 2019 | 71 | 0.310 |
Why?
|
Obesity | 4 | 2009 | 855 | 0.310 |
Why?
|
Logistic Models | 8 | 2016 | 962 | 0.310 |
Why?
|
Pacemaker, Artificial | 1 | 2008 | 2 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 1 | 2008 | 32 | 0.300 |
Why?
|
Defibrillators, Implantable | 1 | 2008 | 32 | 0.300 |
Why?
|
Severity of Illness Index | 5 | 2016 | 476 | 0.300 |
Why?
|
Myocardial Infarction | 2 | 2022 | 249 | 0.300 |
Why?
|
Disabled Persons | 1 | 2008 | 41 | 0.300 |
Why?
|
Depression | 3 | 2014 | 518 | 0.290 |
Why?
|
Pandemics | 3 | 2023 | 292 | 0.290 |
Why?
|
Sex Factors | 8 | 2016 | 661 | 0.290 |
Why?
|
Treatment Outcome | 7 | 2016 | 1296 | 0.290 |
Why?
|
Health Services | 2 | 2016 | 117 | 0.290 |
Why?
|
Pneumonia | 3 | 2016 | 56 | 0.280 |
Why?
|
Insurance Claim Reporting | 1 | 2006 | 8 | 0.280 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 656 | 0.280 |
Why?
|
Alaska Natives | 2 | 2016 | 5 | 0.280 |
Why?
|
Respiratory Tract Infections | 4 | 2015 | 54 | 0.270 |
Why?
|
Chronic Disease | 1 | 2009 | 468 | 0.270 |
Why?
|
Cat-Scratch Disease | 1 | 2005 | 1 | 0.260 |
Why?
|
Follow-Up Studies | 5 | 2021 | 1269 | 0.260 |
Why?
|
Comorbidity | 5 | 2019 | 619 | 0.260 |
Why?
|
Blastomycosis | 2 | 2015 | 2 | 0.250 |
Why?
|
Leiomyoma | 2 | 2002 | 12 | 0.250 |
Why?
|
Alaska | 9 | 2016 | 16 | 0.250 |
Why?
|
Private Sector | 2 | 2002 | 16 | 0.240 |
Why?
|
Synostosis | 1 | 2004 | 1 | 0.240 |
Why?
|
Tarsal Bones | 1 | 2004 | 1 | 0.240 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2004 | 4 | 0.240 |
Why?
|
Spine | 1 | 2004 | 7 | 0.240 |
Why?
|
Sex Distribution | 8 | 2018 | 198 | 0.240 |
Why?
|
Carpal Bones | 1 | 2004 | 3 | 0.240 |
Why?
|
Trauma Severity Indices | 2 | 2016 | 9 | 0.230 |
Why?
|
Asthma | 2 | 2019 | 390 | 0.230 |
Why?
|
Vaccination | 4 | 2019 | 674 | 0.230 |
Why?
|
Hospitals, Urban | 4 | 2016 | 13 | 0.230 |
Why?
|
Health Care Surveys | 4 | 2017 | 247 | 0.230 |
Why?
|
Child, Hospitalized | 2 | 2003 | 15 | 0.230 |
Why?
|
Data Collection | 3 | 2013 | 275 | 0.230 |
Why?
|
Subacute Care | 2 | 2021 | 2 | 0.220 |
Why?
|
Hospitals | 3 | 2014 | 80 | 0.220 |
Why?
|
Regression Analysis | 3 | 2016 | 319 | 0.210 |
Why?
|
Health Care Costs | 5 | 2014 | 251 | 0.210 |
Why?
|
Probability | 2 | 2016 | 86 | 0.210 |
Why?
|
Wounds, Gunshot | 1 | 2003 | 19 | 0.210 |
Why?
|
Venous Thrombosis | 1 | 2022 | 21 | 0.210 |
Why?
|
Public Health Informatics | 1 | 2002 | 8 | 0.210 |
Why?
|
Public Sector | 1 | 2002 | 9 | 0.210 |
Why?
|
Database Management Systems | 1 | 2002 | 15 | 0.210 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 44 | 0.200 |
Why?
|
Endometrium | 1 | 2002 | 2 | 0.200 |
Why?
|
Menorrhagia | 1 | 2002 | 3 | 0.200 |
Why?
|
Catheter Ablation | 1 | 2002 | 11 | 0.200 |
Why?
|
Prevalence | 9 | 2019 | 911 | 0.200 |
Why?
|
Skilled Nursing Facilities | 1 | 2021 | 8 | 0.200 |
Why?
|
Mastectomy | 1 | 2001 | 39 | 0.200 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 172 | 0.190 |
Why?
|
Disease Outbreaks | 4 | 2009 | 39 | 0.190 |
Why?
|
Blood Pressure | 1 | 2023 | 310 | 0.190 |
Why?
|
Heart Failure | 2 | 2016 | 398 | 0.190 |
Why?
|
Epidemics | 2 | 2018 | 6 | 0.190 |
Why?
|
Insurance Claim Review | 2 | 2012 | 70 | 0.180 |
Why?
|
Medically Uninsured | 6 | 2017 | 61 | 0.180 |
Why?
|
Physician Executives | 2 | 1997 | 4 | 0.180 |
Why?
|
Colorado | 1 | 2021 | 211 | 0.180 |
Why?
|
Knee Joint | 1 | 2020 | 4 | 0.180 |
Why?
|
Physical Therapy Modalities | 1 | 2020 | 3 | 0.180 |
Why?
|
Health Care Rationing | 2 | 2002 | 14 | 0.180 |
Why?
|
Respiratory Syncytial Virus, Human | 3 | 2015 | 17 | 0.170 |
Why?
|
Hospital Charges | 4 | 2008 | 8 | 0.170 |
Why?
|
Cost of Illness | 2 | 2014 | 100 | 0.170 |
Why?
|
Physicians | 2 | 2018 | 141 | 0.170 |
Why?
|
Population Groups | 2 | 2016 | 8 | 0.170 |
Why?
|
Health Status Disparities | 2 | 2011 | 153 | 0.170 |
Why?
|
Bacteria | 1 | 2019 | 6 | 0.170 |
Why?
|
Bacterial Infections | 1 | 2019 | 10 | 0.170 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 15 | 0.170 |
Why?
|
Denmark | 2 | 2016 | 19 | 0.170 |
Why?
|
Physician Incentive Plans | 1 | 1999 | 9 | 0.160 |
Why?
|
Sarcoidosis | 1 | 2018 | 2 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2012 | 598 | 0.160 |
Why?
|
Licensure | 1 | 2018 | 5 | 0.160 |
Why?
|
African Americans | 3 | 2018 | 490 | 0.160 |
Why?
|
Laser Therapy | 2 | 1997 | 2 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2019 | 157 | 0.150 |
Why?
|
Seizures | 1 | 2018 | 30 | 0.150 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 13 | 0.150 |
Why?
|
Intensive Care Units | 1 | 1999 | 106 | 0.150 |
Why?
|
Hospitals, Rural | 2 | 2016 | 6 | 0.150 |
Why?
|
Risk | 2 | 2022 | 552 | 0.150 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 142 | 0.150 |
Why?
|
Poison Control Centers | 2 | 2008 | 2 | 0.150 |
Why?
|
Poisoning | 2 | 2008 | 4 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 12 | 0.150 |
Why?
|
Decision Making, Organizational | 1 | 1997 | 4 | 0.150 |
Why?
|
Diagnosis-Related Groups | 5 | 2016 | 27 | 0.140 |
Why?
|
Survivors | 2 | 2016 | 158 | 0.140 |
Why?
|
Greece | 1 | 2016 | 1 | 0.140 |
Why?
|
Smoke-Free Policy | 1 | 2016 | 6 | 0.140 |
Why?
|
Spain | 1 | 2016 | 5 | 0.140 |
Why?
|
Government Agencies | 1 | 2016 | 5 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 8 | 0.140 |
Why?
|
Canada | 1 | 2016 | 67 | 0.140 |
Why?
|
Patient Selection | 2 | 2014 | 198 | 0.140 |
Why?
|
Linear Models | 4 | 2008 | 243 | 0.140 |
Why?
|
Death Certificates | 2 | 2013 | 19 | 0.140 |
Why?
|
Nurse-Patient Relations | 1 | 2016 | 8 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 197 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 22 | 0.130 |
Why?
|
Candidiasis | 1 | 2016 | 2 | 0.130 |
Why?
|
Pneumococcal Infections | 2 | 2013 | 53 | 0.130 |
Why?
|
Decision Making | 2 | 2014 | 204 | 0.130 |
Why?
|
Internet | 1 | 2018 | 243 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 2 | 2017 | 407 | 0.130 |
Why?
|
Cross Infection | 1 | 2016 | 28 | 0.130 |
Why?
|
Antibodies, Viral | 2 | 2015 | 65 | 0.130 |
Why?
|
Social Class | 1 | 2016 | 125 | 0.130 |
Why?
|
Economic Competition | 2 | 2014 | 3 | 0.130 |
Why?
|
Focus Groups | 1 | 2016 | 154 | 0.130 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 743 | 0.130 |
Why?
|
Risk Factors | 10 | 2017 | 3449 | 0.130 |
Why?
|
Propensity Score | 1 | 2016 | 94 | 0.130 |
Why?
|
Topography, Medical | 1 | 2015 | 5 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2017 | 166 | 0.130 |
Why?
|
Chemoprevention | 1 | 2015 | 12 | 0.130 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 21 | 0.130 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2013 | 56 | 0.130 |
Why?
|
Emergency Medical Services | 2 | 2017 | 47 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 6 | 0.120 |
Why?
|
Environment | 1 | 2015 | 51 | 0.120 |
Why?
|
Leptospirosis | 1 | 2014 | 1 | 0.120 |
Why?
|
State Government | 2 | 2006 | 14 | 0.120 |
Why?
|
Meningococcal Infections | 1 | 2014 | 17 | 0.120 |
Why?
|
Breast Neoplasms | 2 | 2005 | 1037 | 0.120 |
Why?
|
Communication | 1 | 2016 | 202 | 0.120 |
Why?
|
Mindfulness | 1 | 2014 | 27 | 0.120 |
Why?
|
Double-Blind Method | 2 | 2013 | 165 | 0.120 |
Why?
|
Technology Transfer | 1 | 2014 | 1 | 0.120 |
Why?
|
Encephalitis | 1 | 2014 | 6 | 0.120 |
Why?
|
Carrier State | 1 | 2013 | 8 | 0.120 |
Why?
|
Chickenpox | 1 | 2014 | 38 | 0.110 |
Why?
|
Food, Fortified | 1 | 2013 | 5 | 0.110 |
Why?
|
Milk | 1 | 2013 | 8 | 0.110 |
Why?
|
Smoking | 1 | 2016 | 494 | 0.110 |
Why?
|
Health Services Needs and Demand | 3 | 2016 | 109 | 0.110 |
Why?
|
Meningitis, Cryptococcal | 1 | 2013 | 1 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 22 | 0.110 |
Why?
|
Endovascular Procedures | 1 | 2013 | 6 | 0.110 |
Why?
|
Chickenpox Vaccine | 1 | 2014 | 101 | 0.110 |
Why?
|
Risk Adjustment | 2 | 2012 | 32 | 0.110 |
Why?
|
United States Indian Health Service | 4 | 2015 | 7 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 131 | 0.110 |
Why?
|
Catastrophic Illness | 1 | 2012 | 1 | 0.100 |
Why?
|
Vitamin D | 1 | 2013 | 80 | 0.100 |
Why?
|
Capitation Fee | 1 | 2012 | 12 | 0.100 |
Why?
|
Models, Biological | 1 | 2012 | 32 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2012 | 28 | 0.100 |
Why?
|
Medicare Part C | 1 | 2012 | 22 | 0.100 |
Why?
|
Cohort Studies | 4 | 2015 | 2672 | 0.100 |
Why?
|
Confidence Intervals | 4 | 2012 | 253 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2010 | 167 | 0.100 |
Why?
|
Geography | 3 | 2016 | 41 | 0.100 |
Why?
|
Empyema | 1 | 2011 | 1 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 630 | 0.100 |
Why?
|
Outpatients | 2 | 2012 | 111 | 0.090 |
Why?
|
Neoplasms | 1 | 2016 | 457 | 0.090 |
Why?
|
Acute Disease | 3 | 2018 | 144 | 0.090 |
Why?
|
Public Health Surveillance | 2 | 2022 | 45 | 0.090 |
Why?
|
Peptic Ulcer | 1 | 2010 | 14 | 0.090 |
Why?
|
Aging | 1 | 2012 | 165 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2010 | 47 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 38 | 0.090 |
Why?
|
Bronchiectasis | 1 | 2010 | 7 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 127 | 0.090 |
Why?
|
Survival Rate | 1 | 2010 | 269 | 0.090 |
Why?
|
California | 3 | 2013 | 2365 | 0.090 |
Why?
|
Mycobacterium Infections | 1 | 2009 | 1 | 0.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 6 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2009 | 15 | 0.090 |
Why?
|
Pregnancy | 4 | 2009 | 1516 | 0.090 |
Why?
|
Infant, Low Birth Weight | 2 | 2007 | 37 | 0.090 |
Why?
|
Models, Economic | 1 | 2009 | 22 | 0.080 |
Why?
|
Utilization Review | 3 | 2008 | 56 | 0.080 |
Why?
|
Public Health | 1 | 1989 | 82 | 0.080 |
Why?
|
Health Policy | 1 | 2010 | 136 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 321 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2007 | 270 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2008 | 5 | 0.080 |
Why?
|
Bronchiolitis, Viral | 1 | 2007 | 1 | 0.080 |
Why?
|
ROC Curve | 1 | 2008 | 83 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2008 | 28 | 0.080 |
Why?
|
Socioeconomic Factors | 4 | 2016 | 673 | 0.070 |
Why?
|
Infant, Premature, Diseases | 1 | 2007 | 16 | 0.070 |
Why?
|
History, 21st Century | 2 | 2019 | 25 | 0.070 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2006 | 1 | 0.070 |
Why?
|
Whooping Cough | 1 | 2008 | 75 | 0.070 |
Why?
|
Infant, Premature | 1 | 2007 | 60 | 0.070 |
Why?
|
Pneumonia, Viral | 1 | 2007 | 57 | 0.070 |
Why?
|
Public Policy | 1 | 2006 | 17 | 0.070 |
Why?
|
Diarrhea, Infantile | 1 | 2006 | 1 | 0.070 |
Why?
|
Medical Records Department, Hospital | 1 | 2006 | 1 | 0.070 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2005 | 14 | 0.070 |
Why?
|
Mumps | 2 | 1997 | 12 | 0.070 |
Why?
|
Mass Screening | 2 | 2005 | 690 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 89 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 95 | 0.070 |
Why?
|
Anti-Obesity Agents | 1 | 2005 | 18 | 0.060 |
Why?
|
Drug Costs | 1 | 2005 | 40 | 0.060 |
Why?
|
Spatio-Temporal Analysis | 2 | 2015 | 2 | 0.060 |
Why?
|
Climate | 2 | 2015 | 3 | 0.060 |
Why?
|
Emergencies | 2 | 2010 | 6 | 0.060 |
Why?
|
Elective Surgical Procedures | 1 | 2005 | 8 | 0.060 |
Why?
|
Immunization Programs | 3 | 2016 | 68 | 0.060 |
Why?
|
Obstetric Labor Complications | 1 | 2005 | 14 | 0.060 |
Why?
|
Multiple Trauma | 1 | 2004 | 2 | 0.060 |
Why?
|
Cesarean Section | 1 | 2005 | 30 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2004 | 23 | 0.060 |
Why?
|
Syndrome | 1 | 2004 | 29 | 0.060 |
Why?
|
Radiography | 1 | 2004 | 41 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2008 | 195 | 0.060 |
Why?
|
Pedigree | 1 | 2004 | 58 | 0.060 |
Why?
|
Likelihood Functions | 2 | 2015 | 48 | 0.060 |
Why?
|
Women's Health | 1 | 2005 | 207 | 0.060 |
Why?
|
Surveys and Questionnaires | 3 | 1997 | 1389 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 105 | 0.060 |
Why?
|
Sampling Studies | 1 | 2003 | 55 | 0.050 |
Why?
|
Survival Analysis | 2 | 2019 | 226 | 0.050 |
Why?
|
Prognosis | 2 | 2017 | 624 | 0.050 |
Why?
|
Thrombosis | 1 | 2022 | 11 | 0.050 |
Why?
|
Hospital Planning | 1 | 2002 | 1 | 0.050 |
Why?
|
Insurance, Hospitalization | 1 | 2002 | 1 | 0.050 |
Why?
|
Thromboembolism | 1 | 2022 | 34 | 0.050 |
Why?
|
Interinstitutional Relations | 1 | 2002 | 12 | 0.050 |
Why?
|
Uterine Hemorrhage | 1 | 2002 | 9 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2001 | 724 | 0.050 |
Why?
|
Premenopause | 1 | 2002 | 27 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2002 | 41 | 0.050 |
Why?
|
Information Dissemination | 1 | 2002 | 57 | 0.050 |
Why?
|
Mastectomy, Simple | 1 | 2001 | 3 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2002 | 102 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2001 | 23 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2002 | 80 | 0.050 |
Why?
|
Public Health Administration | 1 | 2001 | 6 | 0.050 |
Why?
|
Maternal Health Services | 1 | 2001 | 12 | 0.050 |
Why?
|
Infant Mortality | 1 | 2001 | 22 | 0.050 |
Why?
|
Endarterectomy, Carotid | 1 | 2000 | 7 | 0.050 |
Why?
|
Publishing | 1 | 2000 | 9 | 0.050 |
Why?
|
Information Services | 1 | 2000 | 18 | 0.050 |
Why?
|
Quality Indicators, Health Care | 2 | 2017 | 197 | 0.050 |
Why?
|
Health Services Misuse | 2 | 2016 | 14 | 0.050 |
Why?
|
Mumps Vaccine | 2 | 1997 | 8 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2000 | 133 | 0.040 |
Why?
|
Ethnic Groups | 2 | 2016 | 501 | 0.040 |
Why?
|
Vaccines, Attenuated | 2 | 2010 | 47 | 0.040 |
Why?
|
State Health Plans | 1 | 1999 | 44 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2019 | 66 | 0.040 |
Why?
|
Least-Squares Analysis | 2 | 2010 | 16 | 0.040 |
Why?
|
Health Maintenance Organizations | 1 | 2001 | 479 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2019 | 3 | 0.040 |
Why?
|
Ape Diseases | 1 | 1999 | 2 | 0.040 |
Why?
|
Hawaii | 2 | 2010 | 45 | 0.040 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 1999 | 2 | 0.040 |
Why?
|
Florida | 1 | 1999 | 8 | 0.040 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 21 | 0.040 |
Why?
|
Financing, Personal | 1 | 1999 | 24 | 0.040 |
Why?
|
Massachusetts | 1 | 1999 | 99 | 0.040 |
Why?
|
Direct Service Costs | 1 | 2018 | 10 | 0.040 |
Why?
|
Child Health Services | 1 | 1999 | 129 | 0.040 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 11 | 0.040 |
Why?
|
Mexico | 1 | 2018 | 20 | 0.040 |
Why?
|
United Kingdom | 1 | 2018 | 32 | 0.040 |
Why?
|
Poisson Distribution | 2 | 2010 | 94 | 0.040 |
Why?
|
Rubella Vaccine | 1 | 1997 | 9 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 1998 | 83 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 160 | 0.040 |
Why?
|
Measles Vaccine | 1 | 1997 | 21 | 0.040 |
Why?
|
Vaginal Smears | 2 | 2005 | 50 | 0.040 |
Why?
|
Protective Factors | 1 | 2017 | 33 | 0.040 |
Why?
|
Animals | 2 | 2013 | 261 | 0.040 |
Why?
|
Tobacco Products | 1 | 2016 | 17 | 0.030 |
Why?
|
Taxes | 1 | 2016 | 19 | 0.030 |
Why?
|
New York | 2 | 2009 | 22 | 0.030 |
Why?
|
Algorithms | 1 | 1998 | 241 | 0.030 |
Why?
|
Nurses | 1 | 2016 | 40 | 0.030 |
Why?
|
Immunization, Secondary | 1 | 2016 | 64 | 0.030 |
Why?
|
Orthomyxoviridae | 1 | 2015 | 5 | 0.030 |
Why?
|
Osteoarthritis, Hip | 1 | 2015 | 8 | 0.030 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 11 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 1996 | 44 | 0.030 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2015 | 3 | 0.030 |
Why?
|
Humidity | 1 | 2015 | 2 | 0.030 |
Why?
|
Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2015 | 22 | 0.030 |
Why?
|
Temperature | 1 | 2015 | 18 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2015 | 46 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
History, 20th Century | 1 | 2014 | 10 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2015 | 76 | 0.030 |
Why?
|
Pilot Projects | 1 | 2014 | 237 | 0.030 |
Why?
|
Germany | 1 | 2013 | 14 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2013 | 7 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 9 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 15 | 0.030 |
Why?
|
Hospital Bed Capacity | 2 | 2003 | 7 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2013 | 25 | 0.030 |
Why?
|
Hospitals, Teaching | 2 | 2003 | 17 | 0.030 |
Why?
|
Reference Values | 1 | 2013 | 93 | 0.030 |
Why?
|
Anxiety | 1 | 2014 | 156 | 0.030 |
Why?
|
Coinfection | 1 | 2013 | 30 | 0.030 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2013 | 14 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2013 | 58 | 0.030 |
Why?
|
Parents | 1 | 2016 | 309 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2015 | 256 | 0.030 |
Why?
|
HIV Infections | 2 | 2013 | 695 | 0.030 |
Why?
|
Population Surveillance | 1 | 2014 | 271 | 0.030 |
Why?
|
Mass Vaccination | 1 | 2012 | 22 | 0.030 |
Why?
|
Bronchiolitis | 1 | 2012 | 5 | 0.030 |
Why?
|
Insurance Selection Bias | 1 | 2012 | 5 | 0.030 |
Why?
|
Models, Econometric | 1 | 2012 | 11 | 0.030 |
Why?
|
Measles | 1 | 2012 | 26 | 0.020 |
Why?
|
Minority Groups | 1 | 2012 | 105 | 0.020 |
Why?
|
Registries | 2 | 2005 | 490 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 112 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2010 | 22 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 2010 | 24 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2010 | 6 | 0.020 |
Why?
|
Immunity, Herd | 1 | 2009 | 5 | 0.020 |
Why?
|
Birth Rate | 1 | 2009 | 6 | 0.020 |
Why?
|
Southeastern United States | 1 | 1989 | 8 | 0.020 |
Why?
|
Prospective Studies | 1 | 2013 | 1314 | 0.020 |
Why?
|
Quality Control | 1 | 1989 | 48 | 0.020 |
Why?
|
Laboratories | 1 | 1989 | 23 | 0.020 |
Why?
|
Papanicolaou Test | 1 | 1989 | 38 | 0.020 |
Why?
|
Lung Diseases | 1 | 2009 | 43 | 0.020 |
Why?
|
Specimen Handling | 1 | 1989 | 22 | 0.020 |
Why?
|
Population Dynamics | 1 | 2008 | 6 | 0.020 |
Why?
|
Health Planning | 1 | 2008 | 17 | 0.020 |
Why?
|
Models, Statistical | 1 | 2009 | 185 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 1989 | 188 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2008 | 101 | 0.020 |
Why?
|
Insurance Carriers | 1 | 2007 | 6 | 0.020 |
Why?
|
Patient Transfer | 1 | 2007 | 24 | 0.020 |
Why?
|
Forms and Records Control | 1 | 2006 | 7 | 0.020 |
Why?
|
Rural Population | 1 | 2006 | 52 | 0.020 |
Why?
|
Switzerland | 2 | 1997 | 3 | 0.020 |
Why?
|
Premature Birth | 1 | 2007 | 138 | 0.020 |
Why?
|
Appetite Depressants | 1 | 2005 | 16 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 51 | 0.020 |
Why?
|
Annual Reports as Topic | 1 | 2005 | 1 | 0.020 |
Why?
|
Maternal Mortality | 1 | 2005 | 3 | 0.020 |
Why?
|
Maternal Welfare | 1 | 2005 | 16 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2004 | 10 | 0.020 |
Why?
|
Income | 1 | 2005 | 98 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2005 | 65 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 95 | 0.010 |
Why?
|
Mammography | 1 | 2005 | 174 | 0.010 |
Why?
|
Prenatal Care | 1 | 2005 | 134 | 0.010 |
Why?
|
Odds Ratio | 2 | 1996 | 701 | 0.010 |
Why?
|
Suicide | 1 | 2005 | 126 | 0.010 |
Why?
|
Nursing Staff, Hospital | 1 | 2003 | 12 | 0.010 |
Why?
|
Ownership | 1 | 2003 | 15 | 0.010 |
Why?
|
Continental Population Groups | 1 | 2005 | 315 | 0.010 |
Why?
|
Medical Futility | 1 | 2002 | 1 | 0.010 |
Why?
|
Health Care Sector | 1 | 2002 | 2 | 0.010 |
Why?
|
New Jersey | 1 | 2002 | 6 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2005 | 193 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2005 | 228 | 0.010 |
Why?
|
Reimbursement, Incentive | 1 | 2002 | 31 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2002 | 36 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2000 | 27 | 0.010 |
Why?
|
Animals, Wild | 1 | 1999 | 1 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1999 | 1 | 0.010 |
Why?
|
Cote d'Ivoire | 1 | 1999 | 1 | 0.010 |
Why?
|
Ecosystem | 1 | 1999 | 3 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 4 | 0.010 |
Why?
|
Epidemiologic Factors | 1 | 1999 | 4 | 0.010 |
Why?
|
Liver | 1 | 1999 | 33 | 0.010 |
Why?
|
Program Evaluation | 1 | 1999 | 244 | 0.010 |
Why?
|
Mumps virus | 1 | 1997 | 1 | 0.010 |
Why?
|
Vaccines, Combined | 1 | 1997 | 91 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 399 | 0.010 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 1997 | 67 | 0.010 |
Why?
|
Awareness | 1 | 1996 | 18 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1997 | 1173 | 0.010 |
Why?
|
Varicose Veins | 1 | 1948 | 1 | 0.000 |
Why?
|
Iodine Compounds | 1 | 1948 | 1 | 0.000 |
Why?
|
Iodine | 1 | 1948 | 3 | 0.000 |
Why?
|